2,230
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Long non-coding RNA ROR mitigates cobalt chloride-induced hypoxia injury through regulation of miR-145

, , , &
Pages 2221-2229 | Received 26 Feb 2019, Accepted 10 May 2019, Published online: 05 Jun 2019

References

  • Agha B, Johal A. Facial phenotype in obstructive sleep apnea-hypopnea syndrome: a systematic review and meta-analysis. J Sleep Res. 2017;26:122–131.
  • De Backer W. Obstructive sleep apnea/hypopnea syndrome. Panminerva Med. 2013;55:191–195.
  • McDaid C, Griffin S, Weatherly H, et al. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis. Health Technol Assess. 2009;13:iii–iv, xi–xiv, 1–119, 143–274.
  • Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J. 2009;33:907–914.
  • Basyuni S, Barabas M, Quinnell T. An update on mandibular advancement devices for the treatment of obstructive sleep apnoea hypopnoea syndrome. J Thorac Dis. 2018;10:S48–S56.
  • Yao Q, Wu L, Li J, et al. Global prioritizing disease candidate lncRNAs via a multi-level composite network. Sci. Rep. 2017;7:39516.
  • Zhang J, Zhu Y, Wang R. Long noncoding RNAs in respiratory diseases. Histol Histopathol. 2018;33:747–756.
  • Juan C, Wang Q, Mao Y, et al. Knockdown of LncRNA MALAT1 contributes to cell apoptosis via regulating NF-κB/CD80 axis in neonatal respiratory distress syndrome. Int J Biochem Cell Biol. 2018;104:138–148.
  • Yang S, Chen J, Yu Y, et al. Long noncoding RNA ROR as a novel biomarker for progress and prognosis outcome in human cancer: a meta-analysis in the Asian population. CMAR. 2018;10:4641–4652.
  • Weidle UH, Birzele F, Kollmorgen G, et al. Long non-coding RNAs and their role in metastasis. CGP. 2017;14:143–160.
  • Bauderlique-Le Roy H, Vennin C, Brocqueville G, et al. Enrichment of human stem-like prostate cells with s-SHIP promoter activity uncovers a role in stemness for the long noncoding RNA H19. Stem Cells Dev. 2015;24:1252–1262.
  • Yang Z, Tang Y, Lu H, et al. Long non-coding RNA reprogramming (lncRNA-ROR) regulates cell apoptosis and autophagy in chondrocytes. J Cell Biochem. 2018;119:8432–8440.
  • Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J. 2009;33:1195–1205.
  • Passali D, Corallo G, Yaremchuk S, et al. Oxidative stress in patients with obstructive sleep apnoea syndrome. Acta Otorhinolaryngol Italic. 2015;35:420–425.
  • Liu Y, Zhang R, Ying K. Long noncoding RNAs: novel links in respiratory diseases (review). Mol Med Rep. 2015;11:4025–4031.
  • Lacedonia D, Scioscia G, Pia Palladino G, et al. MicroRNA expression profile during different conditions of hypoxia. Oncotarget. 2018;9:35114–35122.
  • Takahashi K, Yan IK, Haga H, et al. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci. 2014;127:1585–1594.
  • Ding W, Chen X, Li W, et al. Genistein protects genioglossus myoblast against hypoxia-induced injury through PI3K-Akt and ERK MAPK pathways. Sci Rep. 2017;7:5085.
  • Retraction: genistein protects genioglossus myocyte against hypoxia-induced injury through PI3K-Akt and ERK MAPK pathways. J Cell Biochem. 2012;113:1809.
  • Chen Q, Lin RJ, Hong X, et al. Treatment and prevention of inflammatory responses and oxidative stress in patients with obstructive sleep apnea hypopnea syndrome using Chinese herbal medicines. Exp Ther Med. 2016;12:1572–1578.
  • Chu CY, Jin YT, Zhang W, et al. CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer. Int J Oncol. 2016;48:271–280.
  • Zhang W, Li Y, Wang P. Long non-coding RNA-ROR aggravates myocardial ischemia/reperfusion injury. Braz J Med Biol Res. 2018;51:e6555.
  • Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253–1261.
  • Li L, Gu M, You B, et al. Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma. Cancer Sci. 2016;107:1215–1222.
  • Lee JW, Bae SH, Jeong JW, et al. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med. 2004;36:1–12.
  • Zhang J, Liu A, Hou R, et al. Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway. Eur J Pharmacol. 2009;607:6–14.
  • Cho WC, Chow AS, Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol. 2011;8:125–131.
  • Fuse M, Nohata N, Kojima S, et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol. 2011;38:1093–1101.
  • Chiyomaru T, Enokida H, Tatarano S, et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010;102:883–891.
  • Qiu T, Zhou X, Wang J, et al. MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer. FEBS Lett. 2014;588:1168–1177.
  • Zhong F, Xu J, Yang X, et al. miR-145 eliminates lipopolysaccharides-induced inflammatory injury in human fibroblast-like synoviocyte MH7A cells. J Cell Biochem. 2018;119:10059–10066.
  • Wang X, Zhang Y, Wang H, et al. MicroRNA-145 aggravates hypoxia-induced injury by targeting Rac1 in H9c2 cells. Cell Physiol Biochem. 2017;43:1974–1986.
  • Peng WX, Huang JG, Yang L, et al. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer. Mol Cancer. 2017;16:161.